Bioasis Technologies

(OTC) BIOAF

Current Price$0.00

Market CapN/A

Since IPO (2012)-100%

5 Year-100%

1 Year-75%

1 Month+9,900%

Bioasis Technologies Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$269.38K

Net Income (TTM)

$2.88M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

2.62 (High)

Dividend

$0.00

Beta (Volatility)

2.62 (High)

Price

$0.00

Volume

74,000

Open

$0.00

Price

$0.00

Volume

74,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

2.62 (High)

Price

$0.00

Volume

74,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

BIOAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bioasis Technologies

Industry

Biotechnology

Sector

Health Care

CEO

Deborah A. Rathjen, PhD

Website

www.bioasis.us

Headquarters

New Haven, CT 06510, US

BIOAF Financials

Key Financial Metrics (TTM)

Gross Margin

-46%

Operating Margin

-130%

Net Income Margin

-78%

Return on Equity

Return on Capital

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

Volume

74.00K

Avg. Volume

1.17K

Financials (TTM)

Gross Profit

$1.19M

Operating Income

$4.82M

EBITDA

$3.54M

Operating Cash Flow

$3.64M

Capital Expenditure

$0.00

Free Cash Flow

$3.64M

Cash & ST Invst.

$1.73M

Total Debt

$1.90M

Bioasis Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$148.94K

+294.8%

Gross Profit

$71.92K

-290.6%

Gross Margin

-48.29%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$985.67K

+22.5%

EBITDA

$664.03K

+12.9%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Net Cash

$2.06M

-459.2%

Accounts Receivable

$13.85K

N/A

Inventory

$0.00

N/A

Long Term Debt

$713.59K

+37.1%

Short Term Debt

$1.50M

+0.0%

Return on Assets

-1.31%

N/A

Return on Invested Capital

6.76%

N/A

Free Cash Flow

$443.31K

+53.1%

Operating Cash Flow

$443.31K

+53.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

IRBSIR Biosciences Holdings Inc.

IRBSIR Biosciences Holdings Inc.$0.00+0.00%

EMYSFEasy Technologies Inc.

EMYSFEasy Technologies Inc.$0.01+0.00%

TOMDFTodos Medical Ltd.

TOMDFTodos Medical Ltd.$0.00+0.00%

NVNOenVVeno Medical Corporation

NVNOenVVeno Medical Corporation$10.50+0.57%

RGMPRegnum Corp.

RGMPRegnum Corp.$0.00+0.00%

GBLXGB Sciences, Inc.

GBLXGB Sciences, Inc.$0.00+0.00%

BLFEBioLife Sciences Inc.

BLFEBioLife Sciences Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About BIOAF

What is the current price of Bioasis Technologies?

Bioasis Technologies is trading at $0.00 per share.

What is the 52-week range for Bioasis Technologies?

Over the past 52 weeks, Bioasis Technologies has traded between $0.00 and $0.00.

How much debt does Bioasis Technologies have?

As of the most recent reporting period, Bioasis Technologies reported total debt of $1.50M.

How much cash does Bioasis Technologies have on hand?

Bioasis Technologies reported $1.36M in cash and cash equivalents in its most recent financial results.

What is Bioasis Technologies’s dividend yield?

Bioasis Technologies does not currently have a dividend yield.

Bioasis Technologies

Bioasis Technologies Financials at a Glance

BIOAF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bioasis Technologies

BIOAF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bioasis Technologies Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BIOAF

What is the current price of Bioasis Technologies?

What is the 52-week range for Bioasis Technologies?

How much debt does Bioasis Technologies have?

How much cash does Bioasis Technologies have on hand?

What is Bioasis Technologies’s dividend yield?

Premium Investing Services